
Last week, the Clinical Research and Equipment industry hasn't moved much but EirGenix is up 3.6% in that time. Unfortunately though, the industry is down 7.1% over the past 12 months.
Has the Taiwanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 21 Jun 2026 | NT$31.9b | NT$2.7b | -NT$747,832,000.00 | 20.7x | -42.6x | 12x |
| Tue, 19 May 2026 | NT$32.3b | NT$2.7b | -NT$746,869,000.00 | 21.4x | -43.2x | 12.2x |
| Thu, 16 Apr 2026 | NT$33.5b | NT$2.5b | -NT$767,980,000.00 | 21.9x | -43.7x | 13.4x |
| Sat, 14 Mar 2026 | NT$31.4b | NT$2.4b | -NT$693,178,000.00 | 19.8x | -45.3x | 12.9x |
| Mon, 09 Feb 2026 | NT$33.3b | NT$2.4b | -NT$689,929,000.00 | 24x | -48.2x | 13.7x |
| Wed, 07 Jan 2026 | NT$33.6b | NT$2.4b | -NT$689,929,000.00 | 25.2x | -48.6x | 13.8x |
| Fri, 05 Dec 2025 | NT$38.0b | NT$2.4b | -NT$670,921,000.00 | 19.6x | -56.7x | 15.6x |
| Sun, 02 Nov 2025 | NT$35.8b | NT$2.5b | -NT$870,437,000.00 | 18.4x | -41.1x | 14.6x |
| Tue, 30 Sep 2025 | NT$36.9b | NT$2.5b | -NT$870,437,000.00 | 19.8x | -42.4x | 15x |
| Thu, 28 Aug 2025 | NT$34.8b | NT$2.5b | -NT$819,216,000.00 | 20.8x | -42.5x | 14.2x |
| Sat, 26 Jul 2025 | NT$34.9b | NT$2.5b | -NT$600,003,000.00 | 21.9x | -58.1x | 14.2x |
| Mon, 23 Jun 2025 | NT$34.3b | NT$2.5b | -NT$600,003,000.00 | 22.6x | -57.1x | 13.9x |
| Wed, 21 May 2025 | NT$32.4b | NT$2.5b | -NT$604,301,000.00 | 23.2x | -53.5x | 13.2x |
| Fri, 18 Apr 2025 | NT$31.6b | NT$2.5b | -NT$540,128,000.00 | 23.7x | -58.5x | 12.8x |
| Sun, 16 Mar 2025 | NT$36.1b | NT$2.6b | -NT$849,328,000.00 | 29.2x | -42.5x | 14x |
| Tue, 11 Feb 2025 | NT$37.8b | NT$2.6b | -NT$854,432,000.00 | 23.2x | -44.2x | 14.7x |
| Thu, 09 Jan 2025 | NT$35.9b | NT$2.6b | -NT$854,432,000.00 | 23.2x | -42x | 14x |
| Sat, 07 Dec 2024 | NT$40.7b | NT$2.6b | -NT$854,432,000.00 | 23.8x | -47.6x | 15.9x |
| Mon, 04 Nov 2024 | NT$42.2b | NT$2.5b | -NT$712,402,000.00 | 24.1x | -59.2x | 16.8x |
| Wed, 02 Oct 2024 | NT$41.9b | NT$2.3b | -NT$836,610,000.00 | 22.3x | -50x | 18.4x |
| Fri, 30 Aug 2024 | NT$40.9b | NT$2.3b | -NT$836,610,000.00 | 22.2x | -48.9x | 18x |
| Sun, 28 Jul 2024 | NT$42.7b | NT$2.1b | -NT$797,765,000.00 | 33x | -53.5x | 20x |
| Tue, 25 Jun 2024 | NT$42.3b | NT$2.1b | -NT$797,765,000.00 | 34.3x | -53.1x | 19.8x |
| Thu, 23 May 2024 | NT$40.1b | NT$2.1b | -NT$797,765,000.00 | 32.4x | -50.2x | 18.8x |
| Sat, 20 Apr 2024 | NT$39.4b | NT$2.1b | -NT$923,759,000.00 | 30.2x | -42.6x | 18.6x |
| Mon, 18 Mar 2024 | NT$40.2b | NT$2.1b | -NT$611,433,000.00 | 32.4x | -65.7x | 19.5x |
| Wed, 14 Feb 2024 | NT$43.0b | NT$2.1b | -NT$610,218,000.00 | 32.4x | -70.4x | 20.7x |
| Fri, 12 Jan 2024 | NT$45.3b | NT$2.1b | -NT$610,218,000.00 | 33.6x | -74.2x | 21.8x |
| Sun, 10 Dec 2023 | NT$48.2b | NT$2.1b | -NT$610,218,000.00 | 33.6x | -79.1x | 23.2x |
| Tue, 07 Nov 2023 | NT$49.6b | NT$2.2b | -NT$497,769,000.00 | 32.1x | -99.6x | 22.3x |
| Thu, 05 Oct 2023 | NT$48.9b | NT$2.2b | -NT$497,769,000.00 | 31.2x | -98.3x | 22x |
| Sat, 02 Sep 2023 | NT$43.9b | NT$2.2b | -NT$497,769,000.00 | 31.8x | -88.2x | 19.7x |
| Mon, 31 Jul 2023 | NT$47.5b | NT$2.5b | -NT$274,767,000.00 | 42.9x | -172.9x | 19.4x |
| Wed, 28 Jun 2023 | NT$50.1b | NT$2.5b | -NT$274,767,000.00 | 43.3x | -182.4x | 20.4x |
-182.4x
How does Taiwanese Clinical Research and Equipment compare with similar industries?
| TW Market | 5.27% | |
| Healthcare | 5.72% | |
| Life Sciences | 0.82% | |
| Clinical Research and Equipment | 0.82% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6589 EirGenix | NT$46.45 | 3.6% +NT$484.2m | -29.1% | PS12.4x | |
| 6891 Locus Cell | NT$46.60 | 0.6% +NT$60.0m | 116.7% | PS731.8x | |
| 4133 Abnova (Taiwan) | NT$20.70 | 0.5% +NT$6.1m | -22.8% | PE652.8x |